Browsing byAuthorReid, AT
Showing results 1 to 6 of 6
| Issue Date | Title | Author(s) |
| 2020-04 | Blocking Notch3 Signaling Abolishes MUC5AC Production in Airway Epithelial Cells from Individuals with Asthma. | Reid, AT; Nichol, KS; Chander Veerati, P; Moheimani, F; Kicic, A; Stick, SM; Bartlett, NW; Grainge, CL; Wark, PAB; Hansbro, PM; Knight, DA |
| 2022-09-11 | Endoplasmic reticulum-unfolded protein response signalling is altered in severe eosinophilic and neutrophilic asthma. | Pathinayake, PS; Waters, DW; Nichol, KS; Brown, AC; Reid, AT; Hsu, AC-Y; Horvat, JC; Wood, LG; Baines, KJ; Simpson, JL; Gibson, PG; Hansbro, PM; Wark, PAB |
| 2016-09-22 | The genetic and epigenetic landscapes of the epithelium in asthma | Moheimani, F; Hsu, ACY; Reid, AT; Williams, T; Kicic, A; Stick, SM; Hansbro, PM; Wark, PAB; Knight, DA |
| 2018-08-02 | Influenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC4, in epithelium of asthmatics | Moheimani, F; Koops, J; Williams, T; Reid, AT; Hansbro, PM; Wark, PA; Knight, DA |
| 2018-05-01 | Persistent induction of goblet cell differentiation in the airways: Therapeutic approaches | Reid, AT; Veerati, PC; Gosens, R; Bartlett, NW; Wark, PA; Grainge, CL; Stick, SM; Kicic, A; Moheimani, F; Hansbro, PM; Knight, DA |
| 2020-10-01 | SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro | Hsu, AC-Y; Wang, G; Reid, AT; Veerati, PC; Pathinayake, PS; Daly, K; Mayall, JR; Hansbro, PM; Horvat, JC; Wang, F; Wark, PA |
